Kavya Pharma

Molnupiravir IH.Cas No: 2492423-29-5

Cas No:2349386-89-4

Molnupiravir is indicated for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progression to severe COVID-19 and for whom alternative FDA-authorized COVID-19 treatments are not accessible or clinically appropriate.

Chemical formula :C13H19N3O7

  • 2-Chloromethyl-3,4-dimethoxypyridine HCl CAS : 72830-09-2
  • 5-Difluoromethoxy-2-mercapto-1-H-benzimidazole CAS : 97963-62-7
  • 5-(Difluoro methoxy)-2-{[(3,4 dimethoxypyridin-2-yl)methyl]thio}-1H-benzimidazole (Panto Sulfide) CAS : 102625-64-9
  • 2-Hydroxymethyl-3,5-dimethyl,4-methoxy pyridine CAS 86604-78-6
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine HCl CAS : 86604-75-3
  • 4-(2,3-Epoxy propaneoxy)-Carbazole cas: 51997-51-4
  • 4,5,6,7-tetrahydro thieno[3,2-c]pyridine hydrochloride (Cyclic Amine) cas: 28783-41-7
  • 3-(N-Methyl-N-Pentylamino)propionic acid HCl cas: 625120-81-2
  • 3-(N-Methyl-N-Pentylamino)propionic acid HCl cas: 625120-81-2
  • N-Acetyl-(4-Hydroxy Phenyl) Piperazine CAS : 67914-60-7
  • 3-(N-Methyl ?N-Pentylamino) Propionic Acid Hydrochloride CAS : 625120-81-2